SPECT/CT-imaging
Showing 1 - 25 of >10,000
NSCLC Trial (99mTc-H7ND SPECT/CT imaging performed)
Not yet recruiting
- NSCLC
- 99mTc-H7ND SPECT/CT imaging performed
- (no location specified)
Aug 17, 2023
Breast Cancer Trial in Beijing (99mTc-MY6349 SPECT/CT scan)
Recruiting
- Breast Cancer
- 99mTc-MY6349 SPECT/CT scan
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 24, 2023
Peripheral Arterial Disease, Diabetes Trial in New Haven (SPECT/CT imaging following revascularization procedures, SPECT/CT
Recruiting
- Peripheral Arterial Disease
- Diabetes Mellitus
- SPECT/CT imaging following revascularization procedures
- SPECT/CT imaging
-
New Haven, ConnecticutYale-New Haven Hospital
May 13, 2022
Prostate Cancer Trial in Xi'an (SPECT/CT imaging with 99mTc-P137 nuclide probe)
Not yet recruiting
- Prostate Cancer
- SPECT/CT imaging with 99mTc-P137 nuclide probe
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Jan 3, 2023
99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast
Enrolling by invitation
- Breast Cancer Female
- 99mTc-DARPinG3 SPECT/CT
-
Tomsk, Russian FederationRussia Tomsk NRMC
Jan 23, 2023
Radioiodine Planar andSPECT/CT Imaging With Iodine-123 for
Recruiting
- Thyroid Gland Follicular Carcinoma
- Computed Tomography
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Primary Hyperparathyroidism, Thyroid Disease, Parathyroid Diseases Trial in Ostrava (Conventional (dual-phase) SPECT/CT,
Completed
- Primary Hyperparathyroidism
- +3 more
- Conventional (dual-phase) SPECT/CT
- +3 more
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Dec 6, 2022
Pulmonary Fibrosis Trial in Beijing (99mTc-HFAPI)
Recruiting
- Pulmonary Fibrosis
-
Beijing, Dongcheng, ChinaPeking union medical college hospital
May 5, 2023
Transthyretin Amyloidosis Trial in New York (I 124-Evuzamitide)
Recruiting
- Transthyretin Amyloidosis
- I 124-Evuzamitide
-
New York, New YorkColumbia University Irving Medical Center
Nov 23, 2022
Neuroblastoma Trial in Copenhagen (18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT))
Recruiting
- Neuroblastoma
- 18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT)
-
Copenhagen, DenmarkRigshospitalet, Copenhagen University Hospital
Apr 11, 2023
Neuroendocrine Tumors, Hyperthyroidism, Thyroid Cancer Trial in London (Nuclear Medicine whole-body, SPECT/CT imaging., PET/CT
Recruiting
- Neuroendocrine Tumors
- +3 more
- Nuclear Medicine whole-body
- +4 more
-
London, United KingdomGuy's and St Thomas Hospitals Foundation Trust
Jan 5, 2022
Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell
Active, not recruiting
- Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
- +2 more
- Computed Tomography
- +7 more
-
Seattle, Washington
- +1 more
Jul 18, 2022
Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor Trial in Madison (Single Photon Emission Computed
Not yet recruiting
- Neuroendocrine Tumors
- Somatostatin Receptor-positive Neuroendocrine Tumor
- Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
- +3 more
-
Madison, WisconsinUniversity of Wisconsin - Madison
Nov 2, 2023
Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)
Enrolling by invitation
- Neuroendocrine Tumor Grade 2
- Neuroendocrine Tumor Grade 1
- [203Pb]VMT-α-NET
- SPECT/CT
-
Iowa City, IowaThe University of Iowa
Dec 9, 2022
Acute Lung Injury, COPD (COPD) Trial in New York (radiation, drug, procedure)
Terminated
- Acute Lung Injury
- Chronic Obstructive Pulmonary Disease (COPD)
- SPECT-CT imaging
- +3 more
-
New York, New YorkColumbia University Irving Medical Center
Aug 17, 2021
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Stage IV Liver Cancer Trial in Seattle (Computed Tomography, Single
Recruiting
- Hepatocellular Carcinoma
- +5 more
- Computed Tomography
- +2 more
-
Seattle, Washington
- +1 more
Feb 24, 2022
Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,
Recruiting
- Systemic Amyloidosis
- 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
- 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
-
Knoxville, TennesseeUniversity of Tennessee Graduate School of Medicine
Jul 10, 2023
High Risk Prostate Cancer Trial in Turku (Whole body contrast enhanced computer tomography, 99mTC-HMDP planar bone scintigraphy
Completed
- High Risk Prostate Cancer
- Whole body contrast enhanced computer tomography
- +4 more
-
Turku, FinlandDepartment of Urology
May 3, 2022
Immunomodulatory Effects of PCSK9 Inhibition
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +3 more
- Contrast-enhanced CCTA
- 99mTc-tilmanocept SPECT/CT scanning
-
Boston, MassachusettsMassachusetts General Hospital
Jan 30, 2023
COPD (COPD) Trial in New York (SPECT-CT imaging, AxV-128/Tc)
Recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- SPECT-CT imaging
- AxV-128/Tc
-
New York, New YorkColumbia University Medical Center
Jul 22, 2021
Primary Malignant Liver Tumor Trial in Palo Alto (procedure, device, diagnostic test)
Completed
- Primary Malignant Liver Neoplasm
- Computed Tomography (CT)
- +4 more
-
Palo Alto, CaliforniaStanford University
Dec 8, 2021
Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles (99mTc-based PSMA Imaging and Surgery Agent, Computed
Recruiting
- Prostate Carcinoma
- Recurrent Prostate Carcinoma
- 99mTc-based PSMA Imaging and Surgery Agent
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 21, 2022
Optimization of 99mTc-Sestamibi Activities in SPECT/CT
Completed
- Coronary Heart Disease
-
Metz, Moselle, FranceCHR Metz Thionville
Nov 23, 2021
Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)
Active, not recruiting
- Metastatic Liver Carcinoma
- +3 more
- Angiography
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022